An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell populations including Th17, T follicular helper (Tfh) an ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...

Interior design expert MaCenna Lee restores exterior trim and architectural details in a detailed exterior renovation episode ...

In a randomized clinical trial involving patients with urinary retention, reusable catheters were found to be noninferior to ...

USA: Findings from the nonrandomized STUN-AF study suggest that, among patients undergoing concomitant pulsed-field ablation ...

Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...

Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis” or the "Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

Modern entertainment brands have learned the oldest lesson in behaviour design: people return when effort leaves a mark. That lesson has moved across games, streaming, learning apps and casino-style ...